$256.43
1.12% yesterday
NYSE, Jun 27, 10:10 pm CET
ISIN
US70975L1070
Symbol
PEN

Penumbra, Inc. Stock price

$256.43
-16.20 5.94% 1M
+16.58 6.91% 6M
+18.95 7.98% YTD
+81.53 46.62% 1Y
+123.87 93.44% 3Y
+84.05 48.76% 5Y
+215.13 520.90% 10Y
+215.13 520.90% 20Y
NYSE, Closing price Fri, Jun 27 2025
+2.85 1.12%
ISIN
US70975L1070
Symbol
PEN
Sector

Key metrics

Basic
Market capitalization
$9.9b
Enterprise Value
$9.6b
Net debt
$-355.4m
Cash
$378.9m
Shares outstanding
38.7m
Valuation (TTM | estimate)
P/E
239.65 | 67.42
P/S
8.01 | 7.25
EV/Sales
7.72 | 6.99
EV/FCF
63.69
P/B
8.18
Financial Health
Equity Ratio
75.07%
Return on Equity
1.22%
ROCE
2.62%
ROIC
-
Debt/Equity
0.02
Financials (TTM | estimate)
Revenue
$1.2b | $1.4b
EBITDA
$40.3m | $240.1m
EBIT
$37.5m
Net Income
$42.2m | $147.1m
Free Cash Flow
$150.3m
Growth (TTM | estimate)
Revenue
13.18% | 14.60%
EBITDA
-53.96% | 162.64%
EBIT
-51.66%
Net Income
-54.80% | 950.11%
Free Cash Flow
42.70%
Margin (TTM | estimate)
Gross
66.37%
EBITDA
3.25% | 17.54%
EBIT
3.03%
Net
3.41% | 10.75%
Free Cash Flow
12.12%
More
EPS
$1.07
FCF per Share
$3.89
Short interest
5.51%
Employees
4.50k
Rev per Employee
$270.00k
Show more

Is Penumbra, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Penumbra, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Penumbra, Inc. forecast:

17x Buy
74%
6x Hold
26%

Analyst Opinions

23 Analysts have issued a Penumbra, Inc. forecast:

Buy
74%
Hold
26%

Financial data from Penumbra, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,240 1,240
13% 13%
100%
- Direct Costs 417 417
9% 9%
34%
823 823
15% 15%
66%
- Selling and Administrative Expenses 580 580
12% 12%
47%
- Research and Development Expense 92 92
4% 4%
7%
40 40
54% 54%
3%
- Depreciation and Amortization 2.81 2.81
72% 72%
0%
EBIT (Operating Income) EBIT 38 38
52% 52%
3%
Net Profit 42 42
55% 55%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Penumbra, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Penumbra, Inc. Stock News

Positive
Seeking Alpha
2 days ago
Penumbra's AI-guided aspiration system and scalable platform uniquely position it as a leader in stroke and PE intervention, justifying a Buy rating. First-mover advantage in intelligent thrombectomy, expanding European reimbursement, and an aging population create strong long-term growth tailwinds. Despite premium valuation multiples, PEN's innovation, ecosystem, and divestiture of non-core as...
Neutral
PRNewsWire
12 days ago
STORM-PE is a first-of-its-kind clinical trial comparing computer assisted vacuum thrombectomy (CAVT™) using Penumbra's Lightning Flash™ with anticoagulation versus anticoagulation alone in the treatment of acute intermediate-high risk pulmonary embolism ALAMEDA, Calif. , June 16, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion...
Neutral
PRNewsWire
23 days ago
ALAMEDA, Calif. , June 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby® XL System, the longest, largest and softest coil on the marketi.
More Penumbra, Inc. News

Company Profile

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

Head office United States
CEO Adam Elsesser
Employees 4,500
Founded 2004
Website www.penumbrainc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today